G373-1331 Screening compound: N,N,1-trimethyl-2-{[4-(phenylcarbamoyl)piperazin-1-yl]methyl}-1H-1,3-benzodiazole-5-carboxamide

G373-1331 Screening compound: N,N,1-trimethyl-2-{[4-(phenylcarbamoyl)piperazin-1-yl]methyl}-1H-1,3-benzodiazole-5-carboxamide
G373-1331 Screening compound: N,N,1-trimethyl-2-{[4-(phenylcarbamoyl)piperazin-1-yl]methyl}-1H-1,3-benzodiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G373-1331
N,N,1-trimethyl-2-{[4-(phenylcarbamoyl)piperazin-1-yl]methyl}-1H-1,3-benzodiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G373-1331

Molecular Formula

C23H28N6O2 (C23 H28 N6 O2)

Compound Name

N,N,1-trimethyl-2-{[4-(phenylcarbamoyl)piperazin-1-yl]methyl}-1H-1,3-benzodiazole-5-carboxamide

IUPAC name

NN1-trimethyl-2-{[4-(phenylcarbamoyl)piperazin-1-yl]methyl}-1H-13-benzodiazole-5-carboxamide

SMILES

CN(C)C(c(cc1)cc2c1n(C)c(CN(CC1)CCN1C(Nc1ccccc1)=O)n2)=O

InChI

InChI=1S/C23H28N6O2/c1-26(2)22(30)17-9-10-20-19(15-17)25-21(27(20)3)16-28-11-13-29(14-12-28)23(31)24-18-7-5-4-6-8-18/h4-10,15H,11-14,16H2,1-3H3,(H,24,31)

InChI Key

ZGDMDXFAYKFSEC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15005799

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

420.51

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.844

Distribution Coefficient, logD

0.400

Water Solubility, LogSw

-2.30

Polar Surface Area

57.235

Acid Dissociation Constant (pKa)

14.03

Base Dissociation Constant (pKb)

7.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

G373-1331 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Targeted Diversity Library (40567 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G373-1331 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G373-1331?
Check Price and Availability of G373-1331, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G373-1331 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G373-1331
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G373-1331
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G373-1331 available by request